These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20963551)

  • 1. Using simulation-optimization to construct screening strategies for cervical cancer.
    McLay LA; Foufoulides C; Merrick JR
    Health Care Manag Sci; 2010 Dec; 13(4):294-318. PubMed ID: 20963551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years.
    Creighton P; Lew JB; Clements M; Smith M; Howard K; Dyer S; Lord S; Canfell K
    BMC Public Health; 2010 Nov; 10():734. PubMed ID: 21110881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries.
    Campos NG; Sharma M; Clark A; Lee K; Geng F; Regan C; Kim J; Resch S
    Int J Gynaecol Obstet; 2017 Jul; 138 Suppl 1():47-56. PubMed ID: 28691334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of strategies for cervical cancer prevention in India.
    Chauhan AS; Prinja S; Srinivasan R; Rai B; Malliga JS; Jyani G; Gupta N; Ghoshal S
    PLoS One; 2020; 15(9):e0238291. PubMed ID: 32870941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.
    Armstrong EP
    J Manag Care Pharm; 2010 Apr; 16(3):217-30. PubMed ID: 20331326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact on women's health and the cervical cancer screening budget of primary HPV screening with dual-stain cytology triage in Belgium.
    Tjalma WAA; Kim E; Vandeweyer K
    Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():171-181. PubMed ID: 28081908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of cervical-cancer screening in five developing countries.
    Goldie SJ; Gaffikin L; Goldhaber-Fiebert JD; Gordillo-Tobar A; Levin C; Mahé C; Wright TC;
    N Engl J Med; 2005 Nov; 353(20):2158-68. PubMed ID: 16291985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mammography and cervical cancer screening--a systematic review about women's knowledge, attitudes and participation in Germany].
    Dreier M; Borutta B; Töppich J; Bitzer EM; Walter U
    Gesundheitswesen; 2012 Nov; 74(11):722-35. PubMed ID: 22012563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'It has saved thousands of lives, so why change it?' Content analysis of objections to cervical screening programme changes in Australia.
    Obermair HM; Dodd RH; Bonner C; Jansen J; McCaffery K
    BMJ Open; 2018 Feb; 8(2):e019171. PubMed ID: 29440214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries.
    Campos NG; Sharma M; Clark A; Kim JJ; Resch SC
    PLoS One; 2016; 11(10):e0164000. PubMed ID: 27711124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effective policies for cervical cancer screening. An international review.
    Fahs MC; Plichta SB; Mandelblatt JS
    Pharmacoeconomics; 1996 Mar; 9(3):211-30. PubMed ID: 10160098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Curry SJ; Krist AH; Owens DK; Barry MJ; Caughey AB; Davidson KW; Doubeni CA; Epling JW; Kemper AR; Kubik M; Landefeld CS; Mangione CM; Phipps MG; Silverstein M; Simon MA; Tseng CW; Wong JB
    JAMA; 2018 Aug; 320(7):674-686. PubMed ID: 30140884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of cervical cancer screening: comparison of screening policies.
    van den Akker-van Marle ME; van Ballegooijen M; van Oortmarssen GJ; Boer R; Habbema JD
    J Natl Cancer Inst; 2002 Feb; 94(3):193-204. PubMed ID: 11830609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of interactive medical data transfer to increase effectiveness of a mass screening program].
    Knapp P; Zbroch T; Knapp P
    Ginekol Pol; 2004 Nov; 75(11):896-903. PubMed ID: 15754581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine.
    Goldie SJ; Kohli M; Grima D; Weinstein MC; Wright TC; Bosch FX; Franco E
    J Natl Cancer Inst; 2004 Apr; 96(8):604-15. PubMed ID: 15100338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
    Simms KT; Steinberg J; Caruana M; Smith MA; Lew JB; Soerjomataram I; Castle PE; Bray F; Canfell K
    Lancet Oncol; 2019 Mar; 20(3):394-407. PubMed ID: 30795950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis.
    Kulasingam SL; Rajan R; St Pierre Y; Atwood CV; Myers ER; Franco EL
    BMC Med; 2009 Nov; 7():69. PubMed ID: 19900264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of HPV sample self-collection for underscreened women in the renewed Cervical Screening Program.
    Smith M; Lew JB; Simms K; Canfell K
    Med J Aust; 2016 Mar; 204(5):1941e-7. PubMed ID: 26985849
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.